Medical Cannabis Research Act of 2019
USA116th CongressHR-601| House
| Updated: 3/4/2019
Matt Gaetz
Republican Representative
Florida
Cosponsors (12)
Darren Soto (Democratic)Ken Buck (Republican)Jimmy Panetta (Democratic)Scott H. Peters (Democratic)David P. Joyce (Republican)Joe Cunningham (Democratic)Rodney Davis (Republican)W. Gregory Steube (Republican)Mary Gay Scanlon (Democratic)Diana DeGette (Democratic)Charlie Crist (Democratic)Chellie Pingree (Democratic)
Committees (6)
• Crime and Federal Government Surveillance Subcommittee• Health Subcommittee• Veterans' Affairs Committee• Health Subcommittee• Judiciary Committee• Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Medical Cannabis Research Act of 2019 This bill establishes a new, separate registration process for manufacturers of cannabis for research. As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers. The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Health
Drug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesHealth programs administration and fundingLicensing and registrationsMedical researchVeterans' medical care
Medical Cannabis Research Act of 2019
USA116th CongressHR-601| House
| Updated: 3/4/2019
Medical Cannabis Research Act of 2019 This bill establishes a new, separate registration process for manufacturers of cannabis for research. As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers. The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Matt Gaetz
Republican Representative
Florida
Cosponsors (12)
Darren Soto (Democratic)Ken Buck (Republican)Jimmy Panetta (Democratic)Scott H. Peters (Democratic)David P. Joyce (Republican)Joe Cunningham (Democratic)Rodney Davis (Republican)W. Gregory Steube (Republican)Mary Gay Scanlon (Democratic)Diana DeGette (Democratic)Charlie Crist (Democratic)Chellie Pingree (Democratic)
Committees (6)
• Crime and Federal Government Surveillance Subcommittee• Health Subcommittee• Veterans' Affairs Committee• Health Subcommittee• Judiciary Committee• Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Drug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesHealth programs administration and fundingLicensing and registrationsMedical researchVeterans' medical care